Literature DB >> 9626756

Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.

C Gartung1, S Matern.   

Abstract

Impairment of the hepatic transport of bile acids and other organic anions will result in the clinically important syndrome of cholestasis. Cloning of a number of specific hepatic organic anion transporters has enabled studies of their molecular regulation during cholestasis. The best characterized transport system is a 50-51 kDa sodium-dependent taurocholate cotransporting polypeptide (ntcp), which mediates the sodium-dependent uptake of conjugated bile acids at the sinusoidal plasma membrane of hepatocytes. Under physiologic conditions and after depletion of biliary constituents, ntcp remains constitutively expressed throughout the liver acinus. However, both function and expression of ntcp are rapidly down-regulated in rat liver in various models of experimental cholestasis, such as cholestasis induced by common bile duct ligation, estrogen, endotoxin or cytokine treatment. In addition to ntcp, the sinusoidal organic anion transporting polypeptide oatp-1 is also down-regulated at the protein and steady-state mRNA levels in estrogen-cholestasis, but does not affect sodium-independent uptake of taurocholate. The regulation of a recently cloned member of the organic anion transporter family (oatp-2), which is highly expressed in liver, remains to be studied under cholestatic conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9626756      PMCID: PMC2589349     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  40 in total

1.  Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.

Authors:  R M Green; D Beier; J L Gollan
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

2.  Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter.

Authors:  S J Karpen; A Q Sun; B Kudish; B Hagenbuch; P J Meier; M Ananthanarayanan; F J Suchy
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

3.  Estrogen cholestasis. Membranes, metabolites, or receptors?

Authors:  M Vore
Journal:  Gastroenterology       Date:  1987-09       Impact factor: 22.682

4.  Increased membrane fluidity and cholestasis: associated but not linked consequences of estrogen treatment.

Authors:  Y Isaacson; D H Van Thiel
Journal:  J Lab Clin Med       Date:  1988-12

5.  Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.

Authors:  D J Smith; E R Gordon
Journal:  J Lab Clin Med       Date:  1988-12

6.  Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.

Authors:  X Bossuyt; M Müller; B Hagenbuch; P J Meier
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

7.  cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats.

Authors:  M Büchler; J König; M Brom; J Kartenbeck; H Spring; T Horie; D Keppler
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

8.  Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis.

Authors:  U A Boelsterli; G Rakhit; T Balazs
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

9.  Inhibition of Na+, K+-adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis.

Authors:  R Utili; C O Abernathy; H J Zimmerman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

10.  Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.

Authors:  C C Paulusma; P J Bosma; G J Zaman; C T Bakker; M Otter; G L Scheffer; R J Scheper; P Borst; R P Oude Elferink
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

View more
  6 in total

1.  Individual bile acids have differential effects on bile acid signaling in mice.

Authors:  Peizhen Song; Cheryl E Rockwell; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-09       Impact factor: 4.219

Review 2.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

3.  Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.

Authors:  Eva Sticova; Alena Lodererova; Evita van de Steeg; Sona Frankova; Marek Kollar; Vera Lanska; Radana Kotalova; Tomas Dedic; Alfred H Schinkel; Milan Jirsa
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.

Authors:  Alessio Nocentini; Alessandro Bonardi; Simone Pratesi; Paola Gratteri; Carlo Dani; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

6.  Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid.

Authors:  Lianne R de Haan; Joanne Verheij; Rowan F van Golen; Verena Horneffer-van der Sluis; Matthew R Lewis; Ulrich H W Beuers; Thomas M van Gulik; Steven W M Olde Damink; Frank G Schaap; Michal Heger; Pim B Olthof
Journal:  Biomolecules       Date:  2021-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.